Knockdown of METTL3 reduced the proliferation, migration, invasion and DNA synthesis ability of prostate cancer cells, and inhibited tumor formation and reduced lung metastasis (Chen et al., 2021b; Mao et al., 2022). The gene discussed is METTL3; the disease is prostate carcinoma.